Montreal Institute for Genocide and Human Rights Studies

Population Media Center Premieres New Podcast "The State of: Women" Hosted by Comedian Gina Brillon and Journalist Kimberly Brooks

Retrieved on: 
Monday, November 14, 2022

LOS ANGELES, Nov. 14, 2022 /PRNewswire/ -- The State of: Women (TSOW) podcast debuts November 15, co-hosted by actress, comedian, and writer Gina Brillon and TV host and correspondent Kimberly Brooks. The series kicks off with a Facebook Live party streamed on November 15th from 12pm-1pm PST here. Join the celebration with TSOW co-hosts Gina and Kimberly as they interview special guests Emerge President A'shanti F. Gholar and How Women Lead CEO and Founder Julie Castro Abrams. The event will feature DJ Simmy, TSOWpod trivia, and unreleased clips from the premier podcast.

Key Points: 
  • "Laughter is a powerful tool in driving change," said TSOWpod co-host and stand-up comedian Gina Brillon.
  • "Kimberly and I hope this podcast will help people understand their state and country better, while also giving them a much-needed laugh."
  • The State of: Womenis a new podcast with episodes airing every Tuesday, produced by Population Media Center, Clamor, and Reasonable Volume.
  • The State of: Women is created, produced, and distributed by Population Media Center (PMC), a global non-profit impact content producer.

Relation Therapeutics, the Active-Graph Machine Learning Drug Discovery Company, Names David Roblin as CEO and Lindsay Edwards as CTO

Retrieved on: 
Thursday, June 9, 2022

Dr. David Roblin joins the company as Chief Executive Officer and Dr. Lindsay Edwards as Chief Technology Officer and President of Platform.

Key Points: 
  • Dr. David Roblin joins the company as Chief Executive Officer and Dr. Lindsay Edwards as Chief Technology Officer and President of Platform.
  • Our approach brings together, for the first time, human genetics, single-cell omics, functional genomics, and active-graph machine learning in a single, engineered design.
  • With active-graph machine learning, Relation can understand the huge number of combinatorial functional relationships between genes, proteins, and drugs.
  • Roblin has been involved in Relation since its founding, while engaged as CEO of Juvenescence Therapeutics, an early investor in Relation.